Leukemia Inhibitory Factor (LIF) can exacerbate airway hyperresponsiveness but may also provide anti-inflammatory benefits during pneumonia; however, its signaling mechanisms remain unclear [25,26]. This evidence concerns the gene LIF and susceptibility to pneumonia measurement.